Small and neutral TC(V)O BAT, bisaminoethanethiol (N2S2) complexes for developing new brain imaging agents

Nuclear Medicine and Biology

Volumn 25, Issue 2, 1998, Pages 135-140

  Oya, Shunichi ^a   Plössl, Karl ^a   Kung, Mei Ping ^a   Stevenson, D Andrew ^a   Kung, Hank F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Exchange reaction; HPLC; Ligand exchange; Radiochemical purity; Radiolabeling

Indexed keywords

CYSTEAMINE DERIVATIVE; CYSTEINE ETHYL ESTER TC 99M; MERCAPTAMINE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGING SYSTEM; ISOTOPE LABELING; LIGAND BINDING; LIPOPHILICITY; MALE; NONHUMAN; RAT;

ANIMALS; BRAIN; CHEMISTRY, PHYSICAL; CYSTEAMINE; ETHYLENEDIAMINES; INDICATORS AND REAGENTS; LIGANDS; MALE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM;

EID: 0344431340     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00153-4     Document Type: Article

References (16)

1. de Kieviet W. Technetium radiopharmaceuticals Chemical characterization and tissue distribution of Tc-glucoheptonate using Tc-99m and carrier Tc-99 . J. Nucl. Med. 22:(8):1981;703-709.
2. Devous M. D. Sr, Payne J. K., Lowe J. L., Leroy R. F. Comparison of technetium-99m-ECD to xenon-133 SPECT in normal controls and in patients with mild to moderate regional cerebral blood flow abnormalities. J. Nucl. Med. 34:(5):1993;754-761.
3. 2 monoaminemonoamide (MAMA) ligands . Tetrahedron Lett. 32:(40):1991;5485-5488.
4. Jurisson S. S., Berning D., Jia W., Ma D.-S. Coordination compounds in nuclear medicine. Chem. Rev. 93:(3):1993;1137-1156.
5. Kung H. F., Guo Y.-Z., Yu C.-C., Billings J. J., Subramanyam V., Calabrese J. New brain perfusion imaging agents based on Tc-99m bis-amino-ethanethiol (BAT) complexes Stereoisomers and biodistribution . J. Med. Chem. 32:1989;433-437.
6. Kung H. F., Liu B.-L., Wei Y. and Pan S. (1990) Quantitative study of the structure-stability relationship of TcvO(III) complexes. Int. J. Radiat. Appl. Inst. Part A, Appl. Radiat. Isot. 41(8), 773-781.
7. Kung H. F., Molnar M., Billings J. J., Wicks R., Blau M. Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier. J. Nucl. Med. 25:1984;326-332.
8. Kung H. F., Yu C. C., Billings J. J., Molnar M., Blau M. Synthesis of new bis-aminoethanethiol (BAT) derivatives Possible ligands for Tc-99m brain imaging agents . J. Med. Chem. 28:1985;1280-1284.
9. Kung M.-P., Canney D. J., Guo Y.-Z., Billings J. J. and Kung H. F. (1992) Iodinated derivatives of tetrabenazine for mapping monoamine storage sites. Soc. Neurosci. (Abstract No. 202.13) 18, 475.
10. Nishimura O., Kitada C., Fujino M. New method for removing the S-p-methoxybenzyl and S-t-butyl groups of cysteine residues with mercuric trifluoroacetate. Chem. Pharmacol. Bull. 26:(5):1978;1576-1585.
11. Perrin D. D., Armarego W. L. F. Purification of Laboratory Chemicals. 1988;Pergamon Press, New York.
12. Rao T. N., Adhikesavalu D., Camerman A., Fritzberg A. R. Technetium(V) and rhenium(V) complexes of 2,3-bis(mercaptoacetamido)propanoate Chelate ring stereochemistry and influence on chemical and biological properties . J. Am. Chem. Soc. 112:1990;5798-5804.
13. Steigman J., Eckelman W. C. The Chemistry of Technetium in Medicine. 1992;National Academy, Washington, DC.
14. Still W. C., Kahn M., Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 43:1978;2923-2925.
15. 99mTc]-ECD). J. Cereb. Blood Flow Metab. 1:(Suppl):1994;S4-S11.
16. Walovitch R. C., Hill T. C., Garrity S. T., Cheesman E. H., Burgess B. A., O'Leary D. H., et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1 Pharmacology of technetium-99m ECD in non-human primates . J. Nucl. Med. 30:(11):1989;1892-1901.